Skip to main content

The Globe and Mail

Valeant Pharmaceuticals Intl Inc (VRX-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 24.72
Day High 26.63
Open:25.50
Price movement based on the high, low and last over the given period.
Previous Close
Volume
Average Volume
Price/Earnings (TTM)
Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share ttm
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings ttm
Annual Dividend & Yield
Ex-Div Date
Forward P/E
Price/Book
Most Recent Split

Financials

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Quotidian Technical Highlights on Selected Healthcare Stocks -- Quidel, PetMed Express, Valeant Pharma, and Aradigm
PR Newswire - Mon Dec 11, 5:20AM CST
PR Newswire - CMTX
Mon Dec 11, 5:20AM CST
In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on QDEL, PETS, VRX, and ARDM which is a click away at http://www.wallstequities.com/registration. Market Realist reported that the Healthcare sector had a strong performance in November 2017. The Health Care Select Sector SPDR ETF (XLV), which tracks the performance of the Healthcare sector, rose 2.9% in November 2017. On a year-to-date basis, it has returned 22.4% as of December 01st, 2017. Pre-market today, WallStEquities.com shifts focus on the performance of Quidel Corp. (NASDAQ: QDEL), PetMed Express Inc. (NASDAQ: PETS), Valeant Pharmaceuticals International Inc. (NYSE: VRX), and Aradigm Corp. (NASDAQ: ARDM). Wall St. Equities has a wide array of free research reports which include today's stock picks, register now to access them at:
Valeant To Participate At The BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference
PR Newswire - Thu Dec 7, 7:00AM CST
PR Newswire - CMTX
Thu Dec 7, 7:00AM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that Scott A. Hirsch, senior vice president and chief business strategy officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference in New York on Dec. 14, 2017 at 2:00 p.m. EST.
Valeant Announces Pricing Of Private Offering Of Senior Notes
PR Newswire - Mon Dec 4, 5:06PM CST
PR Newswire - CMTX
Mon Dec 4, 5:06PM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has priced its previously announced offering of 9.000% senior notes due 2025 (the "Notes"). The aggregate size of the offering reflects an increase of $500,000,000 from the previously announced offering size of $1,000,000,000 to $1,500,000,000. The offering price for the Notes was 98.611%. The offering is expected to close on or about December 18, 2017. Valeant intends to use the net proceeds from this offering, along with cash on hand, to repurchase $1,500,000,000 aggregate principal amount of outstanding notes pursuant to a tender offer announced earlier today, including Valeant Pharmaceuticals International's, a wholly-owned subsidiary of the Company, outstanding 7.000% Senior Notes due 2020 and 6.375% Senior Notes due 2020 and up to $200,000,000 of the Company's outstanding 5.375% Senior Notes due 2020, and to pay related fees and expenses.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 17.73 +49.18% increase
on 11/15/17
Period Open:19.48
Price movement based on the high, low and last over the given period.
26.63 -0.68% decrease
on 12/11/17
+6.97 (+35.78%) increase
since 11/10/17
3-Month 14.01 +88.79% increase
on 11/02/17
Period Open:17.21
Price movement based on the high, low and last over the given period.
26.63 -0.68% decrease
on 12/11/17
+9.24 (+53.69%) increase
since 09/11/17
52-Week 11.20 +136.16% increase
on 04/24/17
Period Open:20.37
Price movement based on the high, low and last over the given period.
26.63 -0.68% decrease
on 12/11/17
+6.08 (+29.85%) increase
since 12/09/16

All market data is provided by Barchart Solutions (will open in new tab). Copyright © 2017.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement